TSX’s Long Game: Is It Positioned for Enduring Success?

The TSX is firmly positioned for long-term success as it keeps powering through market headwinds.

| More on:

The Toronto Stock Exchange is poised for robust earnings growth in 2025, demonstrating remarkable resilience despite tariff headwinds. Many TSX-listed companies have not only preserved their strong market positions and stable business models but also innovated or adapted to a complex environment.

Three high-quality stocks emerge as exceptional choices for long-term investors. Beyond overcoming short-term setbacks, these companies offer opportunities to maximize your money’s growth potential.

Hourglass and stock price chart

Source: Getty Images

Defensive legacy business

Empire Company (TSX:EMP.A), a defensive grocery business, should remain a Canadian food retail industry icon for decades. In 2025, Canadian shoppers are supporting the local economy and buying Canadian products over American goods. According to its President and CEO, Michael Medline, this behaviour is becoming sticky.

Medline added that Empire and the industry are not highly or directly affected by tariffs and can roll with the punches. The Sobeys parent company wants to ensure that no unnecessary costs are passed on to customers. Moreover, the sourcing of U.S. products continues to drop.

Empire delivered positive results across all major financial measures in Q4 fiscal 2025. In the three months ending May 3, 2025, sales and net earnings increased 3% and 16% year-over-year to $7.6 billion and $173 million, respectively. Medline is also excited about the potential of Empire’s e-commerce business, which is another catalyst for growth.

The $12.9 billion company’s legacy business has survived countless recessions. For prospective investors, EMP.A is up 29.3%-plus year-to-date, trading at $56.04 per share with a modest 1.6% dividend yield.

Strong foundation for growth

Growth investors should take notice of Firan Technology Group (TSX:FTG). The stock, at $12.07 per share, has outperformed the TSX year-to-date with a 65.6% market-beating return compared to 12.9%-plus. Its trailing one-year price return is 96.3%-plus. This $314.2 million global company offers design, development, prototypes, and manufacturing solutions for aerospace and defence electronic products and subsystems.

Two core business segments, FTG Circuits (high-quality printed circuit boards or PCBs) and FTG Aerospace (high-quality avionic subsystem hardware), are the revenue generators. In Q1 2025, sales and net earnings rose 22.6% and 36.3% year-over-year to $42.9 million and $3.5 million, respectively.

Management said the quarterly results demonstrate FTG’s commitment to laying a strong foundation for continued growth. Strategic investments are ongoing to drive increased shareholder returns in both the near term and the long term.

Renaissance period

AtkinsRéalis Group (TSX:ATRL) is focused on expanding its nuclear business and maintaining its leadership position in the global infrastructure sector. The $16 billion Canadian engineering giant is ready to capitalize on the global shift towards nuclear power.

According to its CEO, Ian Edwards, a significant renaissance is currently underway in the nuclear power sector. AtkinsRéalis achieved a record backlog of $20.9 billion in Q2 2025, including a 230% year-over-year increase in nuclear business backlog. Edwards said the strong quarterly results reflect the ongoing demand for the company’s unique end-to-end engineering services and nuclear expertise. “We are distinctly positioned to capture significant market opportunities,” he added.

As of this writing, ATRL trades at $97.14 per share (+27.4% year-to-date). Market analysts maintain a consistent positive outlook, with buy or strong buy ratings and a 12-month average price target of $110.

Long-term investments

Canada’s largest stock exchange is well-positioned for enduring success, and so are Empire Company, Firan Technology, and AtkinsRéalis. Investors with long-term horizons can take positions in one or all of them.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Firan Technology Group. The Motley Fool has a disclosure policy.

More on Dividend Stocks

man in bowtie poses with abacus
Dividend Stocks

How Much Canadians Typically Have in a TFSA by Age 55

The average 55-to-59-year-old's TFSA balance is a useful benchmark, but Loblaw shows how investing well can still move the needle.

Read more »

stocks climbing green bull market
Dividend Stocks

The Canadian Dividend Stock I’d Trust When Markets Get Choppy

Intact Financial (TSX:IFC) stock is the TSX dividend fortress that just keeps delivering

Read more »

dividends can compound over time
Dividend Stocks

3 Ultra-High-Yield Dividend Stocks I’m Still Buying

These three ultra-high yields look tempting, but each one pays you in a very different (and with a very different…

Read more »

Aerial view of a wind farm
Dividend Stocks

Maximum TFSA Impact: 2 TSX Stocks to Help Multiply Your Wealth

Want to get more out of your TFSA? These two TSX stocks could help you grow wealth steadily over time.

Read more »

Canada day banner background design of flag
Dividend Stocks

The Very Best Canadian Stocks to Hold Forever in a TFSA

The best Canadian stocks to hold forever in a TFSA, and why CNR, BCE, and GRT.UN offer long‑term stability, income,…

Read more »

House models and one with REIT real estate investment trust.
Dividend Stocks

It’s Time to Buy: 1 Oversold TSX Stock Poised for a Comeback

Here's why this oversold TSX stock, offering a dividend yield above 4%, might just be the best long-term investment you…

Read more »

Concept of rent, search, purchase real estate, REIT
Dividend Stocks

This 10.4% Dividend Stock Pays Cash Every Single Month

Timbercreek’s 10%+ monthly yield is being supported by a growing mortgage book, even as it cleans up older problem assets.

Read more »

middle-aged couple work together on laptop
Dividend Stocks

How to Make Money in a TFSA With Dividend Stocks

Dividend stocks can deliver income as well as capital gains for patient TFSA investors.

Read more »